Post on 09-Apr-2018
transcript
Bayer
CONTOUR®NEXT Portfolio
Ease, Accuracy, AND Savings…now that’s a powerful combination!
All CONTOUR®NEXT meters offer these easy-to-use features• Second-ChanceTM sampling• No CodingTM technology• Fast test time: 5-second countdown• Small blood sample: 0.6 µL• All CONTOUR®NEXT meters use the same test strip – CONTOUR®NEXT test strips
All CONTOUR®NEXT systems are highly accurate • Proprietary mediator: provides increased stability for enhanced accuracy• MULTIPULSETM accuracy technology from Bayer ensures accurate glucose measurements, even when
blood glucose levels are low. Accuracy is not affected by many common interfering substances.*• Advanced algorithm: corrects signals from various sources of error, including temperature, hematocrit,
and user technique
All at Substantial Savings• Cash – Savings of up to 47%1 versus other major brands• Copay – Insured patients can save up to $35† every month• Managed Care – Accepted by most Managed Care Plans• Medicare – Always covered by Medicare Part B†
*IRI Data 52-week period ending 3/30/14.
A personal approach to
Blood Glucose Monitoring
With the CONTOUR®NEXT portfolio from Bayer, there’s an easy and accurate meter to meet many of your patients’ needs
All CONTOUR®NEXT meters use the CONTOUR®NEXT test strips, which are at the lowest everyday shelf price of all leading brands*
Help your patients Save up to $35** Every Month
Give eligible patients the Bayer CONTOUR® Choice discount card or help them download one at ContourChoice.com
• It’s easy and instant• Accepted at 99% of retail pharmacies• Savings, support, special offers and more…
®®
Blood Glucose Monitoring System
®
Blood GlucoseMonitoring System
©2014 Bayer. Bayer (reg’d), the Bayer Cross (reg’d), BREEZE®, CONTOUR®, and the No Coding logo (reg’d), are registered trademarks of Bayer. No Coding™, MultiPulse™ and Second-Chance™ Sampling, are trademarks of Bayer. JOB #13-11796 BAN # 84147869 5/14
† For diabetes monitors, test strips, lancets, and lancing devices, Medicare requires you to pay 20% of the Medicare-approved amount after your yearly Part B deductible.
**Limitations and restrictions apply. Visit ContourChoice.com for details. Eligible privately insured patients pay the first $15 of co-pay on prescription of 300 test strips or less, and this CONTOUR® Choice co-pay card (“card”) will cover up to $35 of remaining co-pay for Bayer test strips. For quantities over 300 test strips, card benefits and patient contributions increase accordingly. Valid up to 12 uses through 12/31/2015. Cash patients can visit ContourChoice.com for separate card and program details. Limit one (1) card per patient. Card cannot be redeemed for cash or combined with other programs, coupons or discounts. Not eligible for government insurance programs (e.g. Medicare / Medicaid). Void where prohibited. Bayer reserves the right to cancel this program without notice. Offer expires 12/31/2015.
*Please refer to the package insert for the CONTOUR®NEXT test strips. 1. Average retail price per 50 ct., IRI data, 52 week period ending 3/30/14.
COMPATIBLE METERS TEST STRIPS
Bayer Test Strips
Meter Compatibility
COMPATIBILITY
• MULTIPULSETM accuracy technology from Bayer ensures accurate glucose measurements, even when blood glucose levels are low. Accuracy is not affected by many common interfering substances.*
• Second-ChanceTM sampling helps prevent wasted test strips
• No CodingTM technology• Sip-in Sampling® quickly sips in
blood sample• Tiny 0.6 µL blood sample• 5-second countdown• Bayer logo printed on test strip
CONTOUR®NEXT test stripsCONTOUR®NEXT meter
CONTOUR®NEXT USB meter
CONTOUR®NEXT EZ meter
CONTOUR®NEXT LINK meter
COMPATIBLE METERS TEST STRIPS
• No CodingTM technology• Sip-in Sampling® quickly sips
in blood sample• Tiny 0.6 µL blood sample• 5-second countdown
CONTOUR® test stripsCONTOUR®
meter
CONTOUR®USB meter
CONTOUR®LINK meter
®®
Blood Glucose Monitoring System
®
Blood GlucoseMonitoring System
Use this card – to give your patients anyone of the following Bayer meters FREE!
CONTOUR®NEXT EZ • CONTOUR®NEXT • CONTOUR®NEXT USB • CONTOUR® • BREEZE®2PHARMACIST REMINDER: Bayer's CONTOUR®NEXT, CONTOUR® and BREEZE®2 Test Strips
and Control Solutions are sold separately.
These products are provided for evaluation purposes only and may not be charged to any patient and the provider may notsubmit a claim for reimbursement to Medicare, Medicaid, or other public or private insurer for the sample product.
©2014 Bayer. Bayer (reg'd), the Bayer Cross (reg'd), CONTOUR®, BREEZE®, and the No Coding logo (reg'd) are registered trademarks of Bayer. No Coding™ is a trademark of Bayer.
*Limitations and restrictions apply. Void where prohibited by law.*Please refer to the package insert for the CONTOUR®NEXT test strips.
®
Bayer BloodGlucose Meters99 FREE!*
• Contact your Bayer Diabetes Care Sales Representative for additional coupons.• Transmit claim on-line to OPTUMRx. For assistance in filing this claim contact
the Help Desk at 1-800-510-4836.• This offer must be accompanied by a prescription for a Bayer or unbranded meter.
Contact physician if no prescription on file.• Processor requires valid Prescriber ID#, Patient Name, and DOB for claim adjudication.• Bayer reserves the right to terminate the program without notice.• The identification number above can be used for all patients (limit 1 meter/patient/12 month period).
Offer void where prohibited by law.
®
Blood GlucoseMonitoring System
®
Blood Glucose Monitoring System
• RxBIN#: 015251• PCN#: PRX2000• Group: BZCN81• ID#: • Expiration Date: 3/31/2015
SA
VE
TH
IS C
OU
PO
N
All meters in the CONTOUR®NEXT portfolio use CONTOUR®NEXT test strips
SA
VE
TH
IS C
OU
PO
N
DO NOT DISCARD –Valuable coupons for
99 FREEMETERS!
Your patients save:Competitor*Bayer
The CONTOUR®NEXT test strips have the lowest everyday shelf-price of all leading brands.*
Bayer CONTOUR®NEXT Strips
Cost vs. the Competition
Up to 47% Less!
OneTouch® Verio®
$79.83
FreeStyle Lite®
$74.13
ACCU-CHEK® Aviva
$75.71
ACCU-CHEK® Aviva Plus
$71.74OneTouch® Ultra®
$71.06
$38.04$38.04
$32.34$32.34$33.92$33.92
$29.95$29.95$29.28$29.28
*Average retail price per 50ct., IRI data, 52 week period ending 3/30/14.
COST vs. COMPETITION
48%
45%
44%
42%
41%$41.79
*Average retail price per 50ct., IRI data, 52 week period ending 3/30/14.
CONTOUR®NEXT Means More Savings
� Managed Care – Accepted by most Managed Care Plans Covered by more than 89% of Managed Care plans.
� Medicare – Portfolio of meters covered by Medicare CONTOUR®NEXT portfolio of meters and CONTOUR®NEXT test strips are ALWAYS covered under Medicare Part B.
� Cash – Save up to 47%* versus other major brandsCONTOUR®NEXT test strips are available at the lowest everyday shelf price of all leading brands.
Cash patients can save up to $25* every month on Bayer test strips online at ContourChoice.com
Example of Savings:One Touch® Verio® (50-ct) $79.83†
CONTOUR®NEXT (50-ct) $41.79†
Patient saves up to 47%* $38.04
Example of Savings:Copay $50.00Patient pays $15.00
Patient saves $35.00
CONTOUR® Choice SAVES UP TO $35.00 INSTANTLY!
SAVINGS
**Limitations and restrictions apply. Visit ContourChoice.com for details. Eligible privately insured patients pay the first $15 of co-pay on prescription of 300 test strips or less, and this CONTOUR® Choice co-pay card (“card”) will cover up to $35 of remaining co-pay for Bayer test strips. For quantities over 300 test strips, card benefits and patient contributions increase accordingly. Valid up to 12 uses through 12/31/2015. Cash patients can visit ContourChoice.com for separate card and program details. Limit one (1) card per patient. Card cannot be redeemed for cash or combined with other programs, coupons or discounts. Not eligible for government insurance programs (e.g. Medicare / Medicaid). Void where prohibited. Bayer reserves the right to cancel this program without notice. Offer expires 12/31/2015.
� Copay – Save up to $35 every month or more**
Are patients paying more than $15 a month on test strip copays?
Now they shouldn’t have to with Bayer’s CONTOUR® Choice card.
INSURED patients can save up to $35 every month on test strips with CONTOUR® Choice card. And now, insured patients who test more, can save more.**
• Savings vary by prescription test strip quantity – test more, save more
• Accepted at 99% of pharmacies• Easy and instant activation
• Bayer test strips are covered by more than 89% of managed care plans
Your patients save:Competitor*Bayer
The CONTOUR®NEXT test strips have the lowest everyday shelf-price of all leading brands.*
Bayer CONTOUR®NEXT Strips
Cost vs. the Competition
Up to 47% Less!
OneTouch® Verio®
$79.83
FreeStyle Lite®
$74.13
ACCU-CHEK® Aviva
$75.71
ACCU-CHEK® Aviva Plus
$71.74OneTouch® Ultra®
$71.06
$38.04$38.04
$32.34$32.34$33.92$33.92
$29.95$29.95$29.28$29.28
*Average retail price per 50ct., IRI data, 52 week period ending 3/30/14.
COST vs. COMPETITION
48%
45%
44%
42%
41%$41.79
*Average retail price per 50ct., IRI data, 52 week period ending 3/30/14.
CONTOUR®NEXT Means More Savings
� Managed Care – Accepted by most Managed Care Plans Covered by more than 89% of Managed Care plans.
� Medicare – Portfolio of meters covered by Medicare CONTOUR®NEXT portfolio of meters and CONTOUR®NEXT test strips are ALWAYS covered under Medicare Part B.
� Cash – Save up to 47%* versus other major brandsCONTOUR®NEXT test strips are available at the lowest everyday shelf price of all leading brands.
Cash patients can save up to $25* every month on Bayer test strips online at ContourChoice.com
Example of Savings:One Touch® Verio® (50-ct) $79.83†
CONTOUR®NEXT (50-ct) $41.79†
Patient saves up to 47%* $38.04
Example of Savings:Copay $50.00Patient pays $15.00
Patient saves $35.00
CONTOUR® Choice SAVES UP TO $35.00 INSTANTLY!
SAVINGS
**Limitations and restrictions apply. Visit ContourChoice.com for details. Eligible privately insured patients pay the first $15 of co-pay on prescription of 300 test strips or less, and this CONTOUR® Choice co-pay card (“card”) will cover up to $35 of remaining co-pay for Bayer test strips. For quantities over 300 test strips, card benefits and patient contributions increase accordingly. Valid up to 12 uses through 12/31/2015. Cash patients can visit ContourChoice.com for separate card and program details. Limit one (1) card per patient. Card cannot be redeemed for cash or combined with other programs, coupons or discounts. Not eligible for government insurance programs (e.g. Medicare / Medicaid). Void where prohibited. Bayer reserves the right to cancel this program without notice. Offer expires 12/31/2015.
� Copay – Save up to $35 every month or more**
Are patients paying more than $15 a month on test strip copays?
Now they shouldn’t have to with Bayer’s CONTOUR® Choice card.
INSURED patients can save up to $35 every month on test strips with CONTOUR® Choice card. And now, insured patients who test more, can save more.**
• Savings vary by prescription test strip quantity – test more, save more
• Accepted at 99% of pharmacies• Easy and instant activation
• Bayer test strips are covered by more than 89% of managed care plans
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CONT
OUR®
NEXT
EZ
met
er re
sults
(mg/
dL)
E D CB
A
A
B
C
D
CONTOUR®NEXT EZ1,2
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT m
eter
resu
lts (m
g/dL
)
E D CB
A
A
B
C
D
CONTOUR®NEXT1,3
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT U
SB m
eter
resu
lts (m
g/dL
)
E D CB
A
A
B
C
D
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT U
SB m
eter
resu
lts (m
g/dL
)
E D CB
A
A
B
C
D
CONTOUR®NEXT USB1,4
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT L
INK
met
er re
sults
(mg/
dL)
E D CB
A
A
B
C
D
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT U
SB m
eter
resu
lts (m
g/dL
)
E D CB
A
A
B
C
D
CONTOUR®NEXT LINK1,5
Proven AccuracyAll meters in the CONTOUR®NEXT portfolio meet the ISO* 15197: 2013 minimum accuracy requirements.
Parkes-Consensus Error Grid Analyses demonstrated excellent agreement between BGMS and reference results for all systems!1
The ISO standard requires 95% of results to fall within ±15 mg/dL of a laboratory reference value for blood glucose concentrations <100 mg/dL and within ±15% of a laboratory reference value for blood glucose concentrations ≥100 mg/dL AND 99% of individual glucose measured values fall within zones A and B of the Consensus Error Grid2
Clinical study findings showed the CONTOUR®NEXT platform of BGMSs (Blood Glucose Monitoring Systems) utilizing the CONTOUR®NEXT test strip were proven accurate both in the laboratory and in the hands of people with diabetes who were naive to the system in both the lower (<100 mg/dL) and higher (≥100 mg/dL) glucose ranges1
* International Organization for Standardization1. Bernstein et al, A New Test Strip Technology Platform for Self Monitoring of Blood Glucose, J Diabetes Sci Technol Vol 7, Issue 5, September 2013 pp 1386-99. 2. Bailey T. et al. User performance evaluation of the CONTOUR® NEXT EZ (CONTOUR® XT) blood glucose monitoring system. Poster presented at: 72nd Scientific Sessions of the American Diabetes Association (ADA), 8-12 June 2012, Philadelphia, PA. 3. Bernstein R et al. User performance evaluation of the CONTOUR NEXT blood glucose monitoring system with the CONTOUR NEXT test strips. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS), 8-10 November 2012, Bethesda, Maryland. 4. Schachner H et al. Performance evaluation of the CONTOUR® NEXT USB blood glucose monitoring system (BGMS) in the hands of users. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS), 8-10 November 2012, Bethesda, Maryland. 5. Wallace J et al. Accuracy of the CONTOUR® NEXT LINK blood glucose monitoring system (BGMS) in the hands of users. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS); November 8-12, 2012; Bethesda, Maryland.
of the CONTOUR®NEXT PortfolioThe Accuracy Numbers...
99% of CONTOUR®NEXT USB1, 99% of CONTOUR®NEXT2 and 100% of CONTOUR®NEXT EZ3 meter results in the hands of trained operators and patients were within Zone A in the Parkes-Consensus Error Grid analysis1,5
99.5% of the CONTOUR®NEXT portfolio of meter results met the ISO® 15197:2013 accuracy requirement1-4
References: 1. Harrison B, Schachner HC, Brown D. Accuracy evaluation of a new blood glucose monitoring system. Poster presented at: 15th Annual Canadian Diabetes Association (CDA)/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference and Annual Meeting; October 10-13, 2012; Vancouver, British Columbia, Canada. 2. Harrison B, Dunne N. Accuracy and precision evaluation of the CONTOUR® NEXT blood glucose monitoring system. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS); November 8-12, 2012; Bethesda, Maryland. 3. Pflug B, Warchal-Windham ME, Goldy A, Chu A. Analytical accuracy evaluation of the CONTOUR® XT blood glucose meter. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS); November 8-12, 2012; Bethesda, Maryland. 4. Bailey TS, Tideman A, Greene C, et al. User performance evaluation of the CONTOUR® NEXT EZ (CONTOUR® XT) blood glucose monitoring system. Poster presented at: 72nd Scientific Sessions of the American Diabetes Association (ADA); June 8-12, 2012; Philadelphia, Pennsylvania. 5. Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23(8):1143-1148.
With the CONTOUR®NEXT portfolio from Bayer, there’s an easy and accurate meter to meet many of your patients’ needs
ACCURACY ACCURACY
Patient Segment:Experienced tester
Already testing
Patient Segment: Newly diagnosed
Easy to test
Patient Segment: Insulin users
Easy and insightful
• Proprietary mediator provides a stable and high signal-to-noise ratio, delivering accurate results, even at low blood glucose concentrations – where reliable readings are critically important.1,2
• MULTIPULSE™ accuracy technology from Bayer ensures accurate glucose measurements, even when blood glucose levels are low. Accuracy is not affected by many common interfering substances.†
• Advanced algorithm corrects signals from various sources of error, including temperature, hematocrit, and user technique.
• Second-Chance™ sampling allows patient to apply more blood to help prevent wasting test strips.
• No Coding™ technology eliminates errors due to user miscoding.
• Sip-in Sampling® technology automatically draws blood into the test chamber.
The CONTOUR®NEXT test strip from Bayer is designed to reduce many common sources of error
Underfill detection ensures an adequate blood sample for an accurate result with every test
(meter and test strip)
Corrections for many common errors, including temperature and user technique
(meter and test strip)
Sip-in Sampling® technologyautomatically draws blood into the test chamber
No interference from maltose, galactose, or oxygen*
Meter
Percentage of accurate results1,2
CONTOUR®NEXT EZ CONTOUR®NEXT CONTOUR®NEXT USB CONTOUR®NEXT LINK
100% 100% 100% 100%
100% 100% 100% 100%
100% 99.8% 100% 100%
98.8% 98.9% 98.0% 98.9%
In the hands of
within ±15mg/dL
within ±15mg/dLIn the hands of
Trained operators
Patients
Trained operators
Patients
Glucose Concentration
Glucose Concentration
<100mg/dL
≥100mg/dL
Zone E Altered clinical action with possibly dangerous consequences
Zone DAltered clinical action with possibly significant medical risk
Zone C Altered clinical action—likely to affect clinical outcome
Zone A No effect on clinical action Zone B Altered clinical action with little or no effect on clinical outcome †Please refer to the package insert for the CONTOUR®NEXT test strips.
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CONT
OUR®
NEXT
EZ
met
er re
sults
(mg/
dL)
E D CB
A
A
B
C
D
CONTOUR®NEXT EZ1,2
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT m
eter
resu
lts (m
g/dL
)
E D CB
A
A
B
C
D
CONTOUR®NEXT1,3
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT U
SB m
eter
resu
lts (m
g/dL
)
E D CB
A
A
B
C
D
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT U
SB m
eter
resu
lts (m
g/dL
)
E D CB
A
A
B
C
D
CONTOUR®NEXT USB1,4
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT L
INK
met
er re
sults
(mg/
dL)
E D CB
A
A
B
C
D
0 100 200 300
YSI results (mg/dL)
400 5000
100
200
300
400
500
CON
TOUR
®NE
XT U
SB m
eter
resu
lts (m
g/dL
)
E D CB
A
A
B
C
D
CONTOUR®NEXT LINK1,5
Proven AccuracyAll meters in the CONTOUR®NEXT portfolio meet the ISO* 15197: 2013 minimum accuracy requirements.
Parkes-Consensus Error Grid Analyses demonstrated excellent agreement between BGMS and reference results for all systems!1
The ISO standard requires 95% of results to fall within ±15 mg/dL of a laboratory reference value for blood glucose concentrations <100 mg/dL and within ±15% of a laboratory reference value for blood glucose concentrations ≥100 mg/dL AND 99% of individual glucose measured values fall within zones A and B of the Consensus Error Grid2
Clinical study findings showed the CONTOUR®NEXT platform of BGMSs (Blood Glucose Monitoring Systems) utilizing the CONTOUR®NEXT test strip were proven accurate both in the laboratory and in the hands of people with diabetes who were naive to the system in both the lower (<100 mg/dL) and higher (≥100 mg/dL) glucose ranges1
* International Organization for Standardization1. Bernstein et al, A New Test Strip Technology Platform for Self Monitoring of Blood Glucose, J Diabetes Sci Technol Vol 7, Issue 5, September 2013 pp 1386-99. 2. Bailey T. et al. User performance evaluation of the CONTOUR® NEXT EZ (CONTOUR® XT) blood glucose monitoring system. Poster presented at: 72nd Scientific Sessions of the American Diabetes Association (ADA), 8-12 June 2012, Philadelphia, PA. 3. Bernstein R et al. User performance evaluation of the CONTOUR NEXT blood glucose monitoring system with the CONTOUR NEXT test strips. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS), 8-10 November 2012, Bethesda, Maryland. 4. Schachner H et al. Performance evaluation of the CONTOUR® NEXT USB blood glucose monitoring system (BGMS) in the hands of users. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS), 8-10 November 2012, Bethesda, Maryland. 5. Wallace J et al. Accuracy of the CONTOUR® NEXT LINK blood glucose monitoring system (BGMS) in the hands of users. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS); November 8-12, 2012; Bethesda, Maryland.
of the CONTOUR®NEXT PortfolioThe Accuracy Numbers...
99% of CONTOUR®NEXT USB1, 99% of CONTOUR®NEXT2 and 100% of CONTOUR®NEXT EZ3 meter results in the hands of trained operators and patients were within Zone A in the Parkes-Consensus Error Grid analysis1,5
99.5% of the CONTOUR®NEXT portfolio of meter results met the ISO® 15197:2013 accuracy requirement1-4
References: 1. Harrison B, Schachner HC, Brown D. Accuracy evaluation of a new blood glucose monitoring system. Poster presented at: 15th Annual Canadian Diabetes Association (CDA)/Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference and Annual Meeting; October 10-13, 2012; Vancouver, British Columbia, Canada. 2. Harrison B, Dunne N. Accuracy and precision evaluation of the CONTOUR® NEXT blood glucose monitoring system. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS); November 8-12, 2012; Bethesda, Maryland. 3. Pflug B, Warchal-Windham ME, Goldy A, Chu A. Analytical accuracy evaluation of the CONTOUR® XT blood glucose meter. Poster presented at: 12th Annual Meeting of the Diabetes Technology Society (DTS); November 8-12, 2012; Bethesda, Maryland. 4. Bailey TS, Tideman A, Greene C, et al. User performance evaluation of the CONTOUR® NEXT EZ (CONTOUR® XT) blood glucose monitoring system. Poster presented at: 72nd Scientific Sessions of the American Diabetes Association (ADA); June 8-12, 2012; Philadelphia, Pennsylvania. 5. Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23(8):1143-1148.
With the CONTOUR®NEXT portfolio from Bayer, there’s an easy and accurate meter to meet many of your patients’ needs
ACCURACY ACCURACY
Patient Segment:Experienced tester
Already testing
Patient Segment: Newly diagnosed
Easy to test
Patient Segment: Insulin users
Easy and insightful
• Proprietary mediator provides a stable and high signal-to-noise ratio, delivering accurate results, even at low blood glucose concentrations – where reliable readings are critically important.1,2
• MULTIPULSE™ accuracy technology from Bayer ensures accurate glucose measurements, even when blood glucose levels are low. Accuracy is not affected by many common interfering substances.†
• Advanced algorithm corrects signals from various sources of error, including temperature, hematocrit, and user technique.
• Second-Chance™ sampling allows patient to apply more blood to help prevent wasting test strips.
• No Coding™ technology eliminates errors due to user miscoding.
• Sip-in Sampling® technology automatically draws blood into the test chamber.
The CONTOUR®NEXT test strip from Bayer is designed to reduce many common sources of error
Underfill detection ensures an adequate blood sample for an accurate result with every test
(meter and test strip)
Corrections for many common errors, including temperature and user technique
(meter and test strip)
Sip-in Sampling® technologyautomatically draws blood into the test chamber
No interference from maltose, galactose, or oxygen*
Meter
Percentage of accurate results1,2
CONTOUR®NEXT EZ CONTOUR®NEXT CONTOUR®NEXT USB CONTOUR®NEXT LINK
100% 100% 100% 100%
100% 100% 100% 100%
100% 99.8% 100% 100%
98.8% 98.9% 98.0% 98.9%
In the hands of
within ±15mg/dL
within ±15mg/dLIn the hands of
Trained operators
Patients
Trained operators
Patients
Glucose Concentration
Glucose Concentration
<100mg/dL
≥100mg/dL
Zone E Altered clinical action with possibly dangerous consequences
Zone DAltered clinical action with possibly significant medical risk
Zone C Altered clinical action—likely to affect clinical outcome
Zone A No effect on clinical action Zone B Altered clinical action with little or no effect on clinical outcome †Please refer to the package insert for the CONTOUR®NEXT test strips.
Bayer
CONTOUR®NEXT Portfolio
Ease, Accuracy, AND Savings…now that’s a powerful combination!
All CONTOUR®NEXT meters offer these easy-to-use features• Second-ChanceTM sampling• No CodingTM technology• Fast test time: 5-second countdown• Small blood sample: 0.6 µL• All CONTOUR®NEXT meters use the same test strip – CONTOUR®NEXT test strips
All CONTOUR®NEXT systems are highly accurate • Proprietary mediator: provides increased stability for enhanced accuracy• MULTIPULSETM accuracy technology from Bayer ensures accurate glucose measurements, even when
blood glucose levels are low. Accuracy is not affected by many common interfering substances.*• Advanced algorithm: corrects signals from various sources of error, including temperature, hematocrit,
and user technique
All at Substantial Savings• Cash – Savings of up to 47%1 versus other major brands• Copay – Insured patients can save up to $35† every month• Managed Care – Accepted by most Managed Care Plans• Medicare – Always covered by Medicare Part B†
*IRI Data 52-week period ending 3/30/14.
A personal approach to
Blood Glucose Monitoring
With the CONTOUR®NEXT portfolio from Bayer, there’s an easy and accurate meter to meet many of your patients’ needs
All CONTOUR®NEXT meters use the CONTOUR®NEXT test strips, which are at the lowest everyday shelf price of all leading brands*
Help your patients Save up to $35** Every Month
Give eligible patients the Bayer CONTOUR® Choice discount card or help them download one at ContourChoice.com
• It’s easy and instant• Accepted at 99% of retail pharmacies• Savings, support, special offers and more…
®®
Blood Glucose Monitoring System
®
Blood GlucoseMonitoring System
©2014 Bayer. Bayer (reg’d), the Bayer Cross (reg’d), BREEZE®, CONTOUR®, and the No Coding logo (reg’d), are registered trademarks of Bayer. No Coding™, MultiPulse™ and Second-Chance™ Sampling, are trademarks of Bayer. JOB #13-11796 BAN # 84147869 5/14
† For diabetes monitors, test strips, lancets, and lancing devices, Medicare requires you to pay 20% of the Medicare-approved amount after your yearly Part B deductible.
**Limitations and restrictions apply. Visit ContourChoice.com for details. Eligible privately insured patients pay the first $15 of co-pay on prescription of 300 test strips or less, and this CONTOUR® Choice co-pay card (“card”) will cover up to $35 of remaining co-pay for Bayer test strips. For quantities over 300 test strips, card benefits and patient contributions increase accordingly. Valid up to 12 uses through 12/31/2015. Cash patients can visit ContourChoice.com for separate card and program details. Limit one (1) card per patient. Card cannot be redeemed for cash or combined with other programs, coupons or discounts. Not eligible for government insurance programs (e.g. Medicare / Medicaid). Void where prohibited. Bayer reserves the right to cancel this program without notice. Offer expires 12/31/2015.
*Please refer to the package insert for the CONTOUR®NEXT test strips. 1. Average retail price per 50 ct., IRI data, 52 week period ending 3/30/14.